CB Therapeutics

CB Therapeutics operates as a synthetic biology company dedicated to developing cannabinoid and tryptamine-based therapeutics. Their mission is to address a range of critical health challenges, including depression, post-traumatic stress disorder (PTSD), opioid addiction, alcoholism, chronic pain, and various other mental health disorders. By leveraging synthetic biology, CB Therapeutics aims to create innovative and effective treatments for these widespread and debilitating conditions, ultimately improving patient outcomes and quality of life.